Skip to Main Content

CHAMPION-AF Clinical Trial (CHAMPION-AF)

Conditions

Diseases of the Cardiovascular System

What is the purpose of this trial?

The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

  • Trial with
    Boston Scientific Corporation
  • Start Date
    07/01/2021
  • End Date
    12/31/2025

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/04/2021
  • Study HIC
    #2000028952